Literature DB >> 24576973

Septal flash predicts cardiac resynchronization therapy response in patients with permanent atrial fibrillation.

L Gabrielli1, G Marincheva2, B Bijnens3, A Doltra2, J M Tolosana2, R Borràs2, M A Castel2, A Berruezo2, J Brugada2, L Mont2, M Sitges4.   

Abstract

AIMS: Patients with heart failure (HF) as well as atrial fibrillation (AF) have suboptimal response to cardiac resynchronization therapy (CRT). Identification of mechanical abnormalities, amenable to correction with CRT, might improve the selection of candidates and CRT efficiency. We evaluated whether abnormal septal motion, assessed by the presence of septal flash (SF) is related to CRT response in patients with AF. METHODS AND
RESULTS: Ninety-four CRT patients with AF were included. Echocardiography was performed in all subjects at baseline and at 12-month follow-up. Abnormal septal motion was defined by the presence of SF (early septal inward/outward motion within the isovolumic contraction period/QRS duration). Response to CRT was defined as a reduction (>15%) of the end-systolic volume of the left ventricle (LV). Univariate and multivariate analyses were performed to identify the predictors of CRT response. The mean age was 69 ± 8 years, 79% were males, and 59% of patients responded to CRT. Cardiovascular death was 14.4% and all-cause mortality was 16.5% during follow-up. Patients with SF at baseline that was acutely corrected by CRT were significantly more likely to respond than patients without SF. Baseline SF was an independent predictor of CRT response (OR 5.24; 95% CI 1.95-14.11).
CONCLUSION: Abnormal septal motion, assessed by the presence of SF, is a mechanism amenable to CRT correction. Its correction is associated with a higher likelihood of CRT response in HF patients with long-standing AF. This could improve the selection of candidates to CRT in a subgroup with particularly poor response and long-term prognosis. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Cardiac resynchronization therapy; Heart failure; Septal flash

Mesh:

Year:  2014        PMID: 24576973     DOI: 10.1093/europace/euu023

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

Review 1.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Tracking Early Systolic Motion for Assessing Acute Response to Cardiac Resynchronization Therapy in Real Time.

Authors:  Manuel Villegas-Martinez; Magnus Reinsfelt Krogh; Øyvind S Andersen; Ole Jakob Sletten; Ali Wajdan; Hans Henrik Odland; Ole Jakob Elle; Espen W Remme
Journal:  Front Physiol       Date:  2022-06-02       Impact factor: 4.755

Review 3.  Septal Flash as a Predictor of Cardiac Resynchronization Therapy Response: A Systematic Review and Meta-Analysis.

Authors:  Sadie Bennett; Jacopo Tafuro; Simon Duckett; Grant Heatlie; Ashish Patwala; Diane Barker; Arzu Cubukcu; Fozia Zahir Ahmed; Chun Shing Kwok
Journal:  J Cardiovasc Echogr       Date:  2022-01-24

4.  Septal flash correction with His-Purkinje pacing predicts echocardiographic response in resynchronization therapy.

Authors:  Margarida Pujol-López; Rafael Jiménez Arjona; Eduard Guasch; Adelina Doltra; Roger Borràs; Ivo Roca Luque; María Ángeles Castel; Paz Garre; Elisenda Ferró; Mireia Niebla; Esther Carro; Elena Arbelo; Marta Sitges; José M Tolosana; Lluís Mont
Journal:  Pacing Clin Electrophysiol       Date:  2022-01-29       Impact factor: 1.912

5.  Impact of septal flash and left ventricle contractile reserve on positive remodeling during 1 year cardiac resynchronization therapy: the multicenter ViaCRT study.

Authors:  Zbigniew Gąsior; Edyta Płońska-Gościniak; Andrzej Kułach; Krystian Wita; Katarzyna Mizia-Stec; Hanna Szwed; Jarosław Kasprzak; Andrzej Tomaszewski; Władysław Sinkiewicz; Celina Wojciechowska
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.